desoxycorticosterone acetate has been researched along with Myotonic Dystrophy in 1 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ZIERLER, KL | 1 |
| LILIENTHAL, JL | 1 |
1 other study available for desoxycorticosterone acetate and Myotonic Dystrophy
| Article | Year |
|---|---|
Sodium loss in man induced by desoxycorticosterone acetate; study in a subject with myotonic dystrophy.
Topics: Adrenal Glands; Desoxycorticosterone Acetate; Humans; Male; Muscular Dystrophies; Myotonic Dystrophy | 1948 |